Artwork

Indhold leveret af Cover2 Resources and Cover 2 Resources. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Cover2 Resources and Cover 2 Resources eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Ep. 261 - The True Cost of the Opioid Crisis

26:44
 
Del
 

Manage episode 247961579 series 1052357
Indhold leveret af Cover2 Resources and Cover 2 Resources. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Cover2 Resources and Cover 2 Resources eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
In August, a closely watched Oklahoma opioid trial concluded. Johnson & Johnson was found guilty of deceptive marketing practices and public nuisance, the judge awarded the state $572 Million to cover the first year of abatement. However, the judge later announced he had made a $107 million miscalculation. Instead of $572 million, the amount awarded to Oklahoma was actually $465 Million. The miscalculation brought an outcry among Oklahoma state attorneys, mental health specialists, and addiction experts. All claim that the true cost of the opioid crisis is much higher than $572 million, and will take at least 20 years to resolve. After this surprising announcement, we decided to try to answer the question: What are the latest cost estimates of the opioid crisis, and how do they correlate to the judgment awarded in Oklahoma? Our guests on today’s episode, Dale Hall and Dr. Christopher Ruhm, share the results of their research. Together, they detail the massive financial burden Big Pharma has placed on our country and break down the Judge’s award against Johnson & Johnson. Join us for today’s podcast with Dale Hall and Dr. Christopher Ruhm, to hear the true cost of the opioid crisis.
  continue reading

284 episoder

Artwork
iconDel
 
Manage episode 247961579 series 1052357
Indhold leveret af Cover2 Resources and Cover 2 Resources. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Cover2 Resources and Cover 2 Resources eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
In August, a closely watched Oklahoma opioid trial concluded. Johnson & Johnson was found guilty of deceptive marketing practices and public nuisance, the judge awarded the state $572 Million to cover the first year of abatement. However, the judge later announced he had made a $107 million miscalculation. Instead of $572 million, the amount awarded to Oklahoma was actually $465 Million. The miscalculation brought an outcry among Oklahoma state attorneys, mental health specialists, and addiction experts. All claim that the true cost of the opioid crisis is much higher than $572 million, and will take at least 20 years to resolve. After this surprising announcement, we decided to try to answer the question: What are the latest cost estimates of the opioid crisis, and how do they correlate to the judgment awarded in Oklahoma? Our guests on today’s episode, Dale Hall and Dr. Christopher Ruhm, share the results of their research. Together, they detail the massive financial burden Big Pharma has placed on our country and break down the Judge’s award against Johnson & Johnson. Join us for today’s podcast with Dale Hall and Dr. Christopher Ruhm, to hear the true cost of the opioid crisis.
  continue reading

284 episoder

Όλα τα επεισόδια

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning